Cargando…

The Cause of Alzheimer’s Disease: The Theory of Multipathology Convergence to Chronic Neuronal Stress

The field of Alzheimer’s disease (AD) research critically lacks an all-inclusive etiology theory that would integrate existing hypotheses and explain the heterogeneity of disease trajectory and pathologies observed in each individual patient. Here, we propose a novel comprehensive theory that we nam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Decourt, Boris, D’Souza, Gary X, Shi, Jiong, Ritter, Aaron, Suazo, Jasmin, Sabbagh, Marwan N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JKL International LLC 2022
Materias:	Opinoin
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782548/ https://www.ncbi.nlm.nih.gov/pubmed/35111361 http://dx.doi.org/10.14336/AD.2021.0529

Ejemplares similares

Challenges in Establishing Vaccine Induced Herd Immunity through Age Specific Community Vaccinations
por: Dassarma, Barsha, et al.
Publicado: (2022)

Does Informant-Based Reporting of Cognitive Decline Correlate with Age-Adjusted Hippocampal Volume in Mild Cognitive Impairment and Alzheimer’s Disease?
por: Sabbagh, Marwan, et al.
Publicado: (2021)

Inappropriate Use of Medication by Elderly, Polymedicated, or Multipathological Patients with Chronic Diseases
por: Pérez-Jover, Virtudes, et al.
Publicado: (2018)

Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia
por: Decourt, Boris, et al.
Publicado: (2022)

Recent Perspectives on APP, Secretases, Endosomal Pathways and How they Influence Alzheimer’s Related Pathological Changes in Down Syndrome
por: DeCourt, Boris, et al.
Publicado: (2013)

Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
por: Decourt, Boris, et al.
Publicado: (2013)

Is diabetes associated with increased pathological burden in Alzheimer's disease?
por: Sadrolashrafi, Kaviyon, et al.
Publicado: (2021)

Critical Appraisal of Amyloid Lowering Agents in AD
por: Decourt, Boris, et al.
Publicado: (2021)

MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease
por: Decourt, Boris, et al.
Publicado: (2020)

Alzheimer's disease drug development pipeline: 2019
por: Cummings, Jeffrey, et al.
Publicado: (2019)

Alzheimer's disease drug development pipeline: 2020
por: Cummings, Jeffrey, et al.
Publicado: (2020)

Alzheimer’s disease beyond amyloid: strategies for future therapeutic interventions
por: Shi, Jiong, et al.
Publicado: (2020)

QPLOT Neurons—Converging on a Thermoregulatory Preoptic Neuronal Population
por: Upton, Brian A., et al.
Publicado: (2021)

Increasing Precision of Clinical Diagnosis of Alzheimer's Disease Using a Combined Algorithm Incorporating Clinical and Novel Biomarker Data
por: Sabbagh, Marwan N., et al.
Publicado: (2017)

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

New Acetylcholinesterase Inhibitors for Alzheimer's Disease
por: Mehta, Mona, et al.
Publicado: (2012)

Editorial Introduction to the Special Issue from the International Symposium on Biomarkers for Alzheimer’s Disease and Related Disorders
por: Sabbagh, Marwan N.
Publicado: (2017)

Broader Considerations of Higher Doses of Donepezil in the Treatment of Mild, Moderate, and Severe Alzheimer's Disease
por: Berk, Camryn, et al.
Publicado: (2012)

Panarchy theory for convergence
por: Sundstrom, Shana M., et al.
Publicado: (2023)

Novel Therapeutics in Alzheimer's Disease
por: Sabbagh, Marwan, et al.
Publicado: (2012)

Editorial: A Time of Transition of Alzheimer's Disease in the Advent of Anti-Amyloid Monoclonal Antibodies
por: Tousi, Babak, et al.
Publicado: (2021)

Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology
por: Sabbagh, Marwan, et al.
Publicado: (2011)

SAT-422 Galanin-Like Peptide Neurons Are Required for Correctly-Timed Puberty Onset in Mice
por: Decourt, Caroline, et al.
Publicado: (2019)

Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia?
por: Crum, Jana, et al.
Publicado: (2018)

Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer’s disease dementia from normal controls: preliminary findings
por: Sabbagh, Marwan N, et al.
Publicado: (2018)

Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
por: Burstein, Aaron H, et al.
Publicado: (2014)

Potential Peripheral Biomarkers for the Diagnosis of Alzheimer's Disease
por: Patel, Seema, et al.
Publicado: (2011)

5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
por: Andrews, Megan, et al.
Publicado: (2018)

Convergence estimates in approximation theory
por: Gupta, Vijay, et al.
Publicado: (2014)

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?
por: Lue, Lih-Fen, et al.
Publicado: (2012)

FDA position statement “Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry”
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

Exploring the Pathogenesis of Alzheimer Disease in Basal Forebrain Cholinergic Neurons: Converging Insights From Alternative Hypotheses
por: Chen, Xu-Qiao, et al.
Publicado: (2019)

Converging links between adult-onset neurodegenerative Alzheimer’s disease and early life neurodegenerative neuronal ceroid lipofuscinosis?
por: Klein, Marcel, et al.
Publicado: (2022)

KIF6 719Arg Carrier Status Association with Homocysteine and C-Reactive Protein in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Patients
por: Malek-Ahmadi, Michael, et al.
Publicado: (2013)

Differences in Cerebrospinal Fluid Biomarkers between Clinically Diagnosed Idiopathic Normal Pressure Hydrocephalus and Alzheimer’s Disease
por: Tsai, Andrew, et al.
Publicado: (2014)

Converging paradigms for environmental health theory and practice.
por: Parkes, Margot, et al.
Publicado: (2003)

Optimization and the ultimate convergence of QCD perturbation theory
por: Stevenson, P M
Publicado: (1982)

Cancer immune resistance: can theories converge?
por: Lu, Rongze, et al.
Publicado: (2017)

Convergent cortical innervation of striatal projection neurons
por: Kress, Geraldine J., et al.
Publicado: (2013)

Converging mediators from immune and trophic pathways to identify Parkinson disease dementia
por: Lue, Lih-Fen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ulnkhhd6slagv08n6av4363nf4